Advanced Endometrial Cancer Recruiting Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0050728 (Advanced Endometrial Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05481645Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.Treatment